Table 3.
Variable | PCS | MCS | ||
---|---|---|---|---|
Mean score | F/t-test | Mean score | F/t-test | |
Patient Factors | ||||
Age | ||||
< 35a | 46.2 | 3.57** | 49.7 | 2.31 |
35–39 | 45.3 | 49.7 | ||
40–44 | 45.0 | 50.8 | ||
45–49 | 44.4 | 50.0 | ||
>50a | 41.7 | 52.7 | ||
Gender | ||||
Male | 45.0 | 0.95 | 51.3 | 1.28 |
Female | 44.2 | 50.2 | ||
Race | ||||
White | 44.2 | 2.19* | 50.6 | 0.49 |
Other | 47.7 | 51.3 | ||
Marital status | ||||
Married/living with partner | 44.7 | 0.75 | 50.7 | 0.05 |
Other | 43.9 | 50.6 | ||
Clinical Factors | ||||
Comorbid conditions | ||||
Yes | 42.0 | 2.38* | 48.7 | 2.10* |
No | 45.0 | 51.0 | ||
Disease Factors | ||||
Malignant disease | ||||
Acute leukemia (AML or ALL) | 44.2 | 0.51 | 50.2 | 0.46 |
Chronic leukemia (CML) | 44.0 | 50.6 | ||
Breast cancer | 44.6 | 51.5 | ||
Lymphoma (Hodgkin’s disease or non-Hodgkin’s lymphoma) |
45.6 | 50.6 | ||
Intensity of treatment before HCT | ||||
Less intense | 45.4 | 2.72** | 50.6 | 0.01 |
More intense | 42.8 | 50.6 | ||
Transplant Factors | ||||
Type of transplant | ||||
Allogeneic | 43.4 | 2.00* | 50.4 | 0.58 |
Autologous | 45.2 | 50.8 | ||
TBI in transplant conditioning regimen |
||||
Yes | 43.4 | 1.80 | 50.3 | 1.02 |
No | 45.1 | 51.2 |
P<0.05;
P<0.01;
P<0.001
a: the pairwise comparison of mean scores among categories (subgroups) is statistically significant with Bonferroni correction for the p-value